Shiseido (SSDOY) vs. Its Rivals Critical Contrast
Shiseido (OTCMKTS: SSDOY) is one of 485 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its competitors? We will compare Shiseido to similar companies based on the strength of its institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.
Risk and Volatility
Shiseido has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500. Comparatively, Shiseido’s competitors have a beta of 1.08, indicating that their average stock price is 8% more volatile than the S&P 500.
This is a summary of current ratings for Shiseido and its competitors, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
As a group, “Pharmaceutical preparations” companies have a potential upside of 44.29%. Given Shiseido’s competitors higher probable upside, analysts plainly believe Shiseido has less favorable growth aspects than its competitors.
Institutional & Insider Ownership
0.1% of Shiseido shares are owned by institutional investors. Comparatively, 47.4% of shares of all “Pharmaceutical preparations” companies are owned by institutional investors. 15.2% of shares of all “Pharmaceutical preparations” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Shiseido pays an annual dividend of $0.21 per share and has a dividend yield of 0.3%. Shiseido pays out 14.6% of its earnings in the form of a dividend. As a group, “Pharmaceutical preparations” companies pay a dividend yield of 2.2% and pay out 32.9% of their earnings in the form of a dividend.
Earnings and Valuation
This table compares Shiseido and its competitors top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Shiseido||$8.97 billion||$202.46 million||43.42|
|Shiseido Competitors||$2.03 billion||$132.98 million||-3.54|
Shiseido has higher revenue and earnings than its competitors. Shiseido is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
This table compares Shiseido and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Shiseido beats its competitors on 7 of the 12 factors compared.
Shiseido Company, Limited produces and sells cosmetics, cosmetics accessories, and toiletries in Japan and internationally. It also produces and sells health and beauty foods, and over-the-counter drugs; and beauty salon products. In addition, the company operates beauty salons, as well as restaurants. Further, it produces and sells cosmetic raw materials, medical-use drugs, medical cosmetics, purification/analytical equipment, and other products. The company sells its products through cosmetic specialty stores, department stores, general merchandise stores, drug stores, and perfumeries, as well as through mail-order. Shiseido Company, Limited was founded in 1872 and is headquartered in Tokyo, Japan.
Receive News & Ratings for Shiseido Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shiseido and related companies with MarketBeat.com's FREE daily email newsletter.